NAFLD: Metabolic make-up of NASH: From fat and sugar to amino acids

Nature Reviews Gastroenterology and Hepatology

Volumn 11, Issue 4, 2014, Pages 205-207

  Sookoian, Silvia ^a   Pirola, Carlos J ^a  

^a Department of Clinical and Molecular Hepatology Institute of Medical Research A Lanari IDIM University of Buenos Aires National Scientific and Technical Research Council ^*  (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; CHONDROITIN SULFATE; FAT; GENOMIC DNA; SUGAR; SERINE;

AMINO ACID METABOLISM; ENZYME MECHANISM; FATTY LIVER; GENE EXPRESSION; GENE LOCUS; GENETIC ASSOCIATION; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LIVER CELL; LIVER FIBROSIS; LIVER METABOLISM; METABOLIC SYNDROME X; METABOLISM; NONALCOHOLIC FATTY LIVER; PATHOGENESIS; PRIORITY JOURNAL; PROTEOMICS; SHORT SURVEY; BIOLOGICAL MODEL; DEFICIENCY; FEMALE; GENETICS; GENOME; MALE;

FEMALE; GENOME; HEPATOCYTES; HUMANS; MALE; MODELS, BIOLOGICAL; MODELS, GENETIC; NON-ALCOHOLIC FATTY LIVER DISEASE; SERINE;

EID: 84898015383     PISSN: 17595045     EISSN: 17595053     Source Type: Journal    
DOI: 10.1038/nrgastro.2014.25     Document Type: Short Survey

References (10)

1. Mardinoglu, A. et al. Genome-scale metabolic modelling of hepatocytes reveals serine deficiency in patients with non-Alcoholic fatty liver disease. Nat. Commun. 5, 3083 (2014).
2. Speliotes, E. K. et al. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet. 7, e1001324 (2011).
3. Newgard, C. B. et al. A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab. 9, 311-326 (2009).
4. Wang, T. J. et al. Metabolite profiles and the risk of developing diabetes. Nat. Med. 17, 448-453 (2011).
5. Shah, S. H. et al. Association of a peripheral blood metabolic profile with coronary artery disease and risk of subsequent cardiovascular events. Circ. Cardiovasc. Genet. 3, 207-214 (2010).
6. Sookoian, S. et al. Epigenetic regulation of insulin resistance in nonalcoholic fatty liver disease: Impact of liver methylation of the peroxisome proliferator-Activated receptor gamma coactivator 1α promoter. Hepatology 52, 1992-2000 (2010).
7. Pirola, C. J. et al. Epigenetic modification of liver mitochondrial DNA is associated with histological severity of nonalcoholic fatty liver disease. Gut 62, 1356-1363 (2013).
8. Sanyal, A. J. et al. Nonalcoholic steatohepatitis: Association of insulin resistance and mitochondrial abnormalities. Gastroenterology 120, 1183-1192 (2001).
9. Sookoian, S. & Pirola, C. J. Meta-Analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease. Hepatology 53, 1883-1894 (2011).
10. Anstee, Q. M. & Day, C. P. The genetics of NAFLD. Nat. Rev. Gastroenterol. Hepatol. 10, 645-655 (2013).